Sabra Health Care REIT, Inc. (SBRA) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SBRA Revenue Growth
Revenue Breakdown (FY 2025)
SBRA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SBRA Revenue Analysis (2014–2025)
As of May 6, 2026, Sabra Health Care REIT, Inc. (SBRA) generated trailing twelve-month (TTM) revenue of $812.8 million, reflecting exceptional growth of +20.8% year-over-year. The most recent quarter (Q1 2026) recorded $221.8 million in revenue, up 4.6% sequentially.
Looking at the longer-term picture, SBRA's 5-year compound annual growth rate (CAGR) stands at +5.3%, indicating steady revenue expansion. The company achieved its highest annual revenue of $774.6 million in 2025, representing a new all-time high.
Revenue diversification analysis shows SBRA's business is primarily driven by Health Care, Resident Service, Ancillary Service (100%). With over half of revenue concentrated in Health Care, Resident Service, Ancillary Service, the company maintains significant focus in this area while developing other growth vectors.
When compared to Real Estate sector peers including WELL (+38.3% YoY), VTR (+20.7% YoY), and OHI (+14.2% YoY), SBRA has underperformed the peer group in terms of revenue growth. Compare SBRA vs WELL →
SBRA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SBRACurrent | $813M | +20.8% | +5.3% | 34.1% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 VTR | $5.8B | +20.7% | +9.0% | 14.2% | |
 OHI | $1.2B | +14.2% | +6.1% | 62.6% | |
 LTC | $263M | +25.3% | +10.5% | 79.4% | |
 CTRE | $476M | +47.6% | +22.1% | 98.7% |
SBRA Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $774.6M | +10.2% | $503.5M | 65.0% | $263.9M | 34.1% |
| 2024 | $703.2M | +8.6% | $476.1M | 67.7% | $257.0M | 36.5% |
| 2023 | $647.5M | +3.6% | $452.3M | 69.8% | $221.7M | 34.2% |
| 2022 | $624.8M | +9.7% | $462.2M | 74.0% | $234.8M | 37.6% |
| 2021 | $569.5M | -4.8% | $428.3M | 75.2% | $210.7M | 37.0% |
| 2020 | $598.6M | -10.4% | $467.0M | 78.0% | $0 | - |
| 2019 | $668.2M | +7.2% | $558.5M | 83.6% | $527.6M | 79.0% |
| 2018 | $623.4M | +53.7% | $573.9M | 92.1% | $307.0M | 49.2% |
| 2017 | $405.6M | +55.7% | $387.8M | 95.6% | $224.4M | 55.3% |
| 2016 | $260.5M | +9.1% | $254.8M | 97.8% | $160.9M | 61.8% |
See SBRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBRA vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonSBRA — Frequently Asked Questions
Quick answers to the most common questions about buying SBRA stock.
Is SBRA's revenue growth accelerating or slowing?
SBRA revenue is accelerating at +20.8% year-over-year, exceeding the 5-year CAGR of +5.3%. TTM revenue reached $813M. Growth momentum has increased versus prior periods.
What is SBRA's long-term revenue growth rate?
Sabra Health Care REIT, Inc.'s 5-year revenue CAGR of +5.3% reflects the sustained expansion pattern. Current YoY growth of +20.8% is above this long-term average.
How is SBRA's revenue distributed by segment?
SBRA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.